Vemula, S.K.; Narala, S.; Uttreja, P.; Narala, N.; Daravath, B.; Kalla, C.S.A.; Baisa, S.; Munnangi, S.R.; Chella, N.; Repka, M.A.
Quality by Design (QbD) Approach to Develop Colon-Specific Ketoprofen Hot-Melt Extruded Pellets: Impact of Eudragit® S 100 Coating on the In Vitro Drug Release. Pharmaceutics 2024, 16, 1265.
https://doi.org/10.3390/pharmaceutics16101265
AMA Style
Vemula SK, Narala S, Uttreja P, Narala N, Daravath B, Kalla CSA, Baisa S, Munnangi SR, Chella N, Repka MA.
Quality by Design (QbD) Approach to Develop Colon-Specific Ketoprofen Hot-Melt Extruded Pellets: Impact of Eudragit® S 100 Coating on the In Vitro Drug Release. Pharmaceutics. 2024; 16(10):1265.
https://doi.org/10.3390/pharmaceutics16101265
Chicago/Turabian Style
Vemula, Sateesh Kumar, Sagar Narala, Prateek Uttreja, Nagarjuna Narala, Bhaskar Daravath, Chamundeswara Srinivasa Akash Kalla, Srikanth Baisa, Siva Ram Munnangi, Naveen Chella, and Michael A. Repka.
2024. "Quality by Design (QbD) Approach to Develop Colon-Specific Ketoprofen Hot-Melt Extruded Pellets: Impact of Eudragit® S 100 Coating on the In Vitro Drug Release" Pharmaceutics 16, no. 10: 1265.
https://doi.org/10.3390/pharmaceutics16101265
APA Style
Vemula, S. K., Narala, S., Uttreja, P., Narala, N., Daravath, B., Kalla, C. S. A., Baisa, S., Munnangi, S. R., Chella, N., & Repka, M. A.
(2024). Quality by Design (QbD) Approach to Develop Colon-Specific Ketoprofen Hot-Melt Extruded Pellets: Impact of Eudragit® S 100 Coating on the In Vitro Drug Release. Pharmaceutics, 16(10), 1265.
https://doi.org/10.3390/pharmaceutics16101265
